ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ABCL AbCellera Biologics Inc

3.73
0.10 (2.75%)
Last Updated: 09:53:13
Delayed by 15 minutes

Period:

Draw Mode:

Volume 66,277
Bid Price 3.72
Ask Price 3.73
News -
Day High 3.73

Low
3.62

52 Week Range

High
8.05

Day Low 3.65
Company Name Stock Ticker Symbol Market Type
AbCellera Biologics Inc ABCL NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.10 2.75% 3.73 09:53:13
Open Price Low Price High Price Close Price Prev Close
3.69 3.65 3.73 3.63
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
490 66,277 $ 3.69 $ 244,813 - 3.62 - 8.05
Last Trade Time Type Quantity Stock Price Currency
09:53:13 99 $ 3.73 USD

AbCellera Biologics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.05B 289.36M - 38.03M -146.4M -0.51 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

AbCellera Biologics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ABCL Message Board. Create One! See More Posts on ABCL Message Board See More Message Board Posts

Historical ABCL Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week3.854.313.623.861,415,480-0.12-3.12%
1 Month4.544.74993.624.161,131,617-0.81-17.84%
3 Months5.155.463.624.721,382,845-1.42-27.57%
6 Months4.066.0553.624.871,437,777-0.33-8.13%
1 Year6.748.053.625.811,943,523-3.01-44.66%
3 Years29.5536.053.6210.601,981,692-25.82-87.38%
5 Years61.0071.913.6212.421,889,981-57.27-93.89%

AbCellera Biologics Description

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Your Recent History

Delayed Upgrade Clock